Lymphovascular invasion as a prognostic factor in melanoma

American Surgeon

Volumn 77, Issue 8, 2011, Pages 992-997

  Egger, Michael E ^a   Gilbert, Julianna E ^a   Burton, Alison L ^a   Mcmasters, Kelly M ^a   Callender, Glenda G ^a   Quillo, Amy R ^a   Brown, Russell E ^a   St Hill, Charles R ^a   Hagendoorn, Lee ^b   Martin II, Robert C G ^a   Stromberg, Arnold J ^c   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

^b Advertek Inc   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM TUMOR; LYMPHOVASCULAR INVASION; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PROGNOSIS; RISK FACTOR; SENTINEL LYMPH NODE METASTASIS; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80052048139     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34. (Pubitemid 32786275)
2. Chao C, Martin RC, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259-64. (Pubitemid 40486765)
3. Scoggins CR, Ross MI, Reintgen DS, et al. Gender-related differences in outcome for melanoma patients. Ann Surg 2006;243:693-8. (Pubitemid 44305591)
4. McMasters KM, Wong SL, Edwards MJ, et al. Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 2001;130:151-6. (Pubitemid 32721662)
5. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307-17. (Pubitemid 44465459)
6. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83. (Pubitemid 29109331)
7. Fallowfield ME, Cook MG. Vascular invasion in malignant melanomas. An independent prognostic variable? Am J Surg Pathol 1989;13:217-20. (Pubitemid 19081704)
8. Nguyen CL, McClay EF, Cole DJ, et al. Melanoma thickness and histology predict sentinel lymph node status. Am J Surg 2001;181:8-11. (Pubitemid 32209113)
9. Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007;109:100-8. (Pubitemid 46120199)
10. Niakosari F, Kahn HJ, McCready D, et al. Lymphatic invasion identified by monoclonal antiBody D2- 40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Arch Dermatol 2008;144:462-7. (Pubitemid 351581102)
11. Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, et al. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998;134:983-7. (Pubitemid 28385320)
12. Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Int J Surg 2008;6:205-9.
13. Doeden K, Ma Z, Narasimhan B, et al. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. J Cutan Pathol 2009;36:772-80.
14. Frankel TL, Griffith KA, Lowe L, et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 2008;15:2403-11.
15. Gajdos C, Griffith KA, Wong SL, et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 2009;115:5752-60.
16. Scoggins CR, Bowen AL, Martin RC, et al. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg 2010;145:622-7.
17. McMasters KM,Wong SL, Edwards MJ, et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:137-41. (Pubitemid 34259698)
18. Petitt M, Allison A, Shimoni T, et al. Lymphatic invasion detected by D2- 40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma. J Am Acad Dermatol 2009;61:819-28.
19. Murali R, Desilva C, Thompson JF, Scolyer RA. Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. J Clin Oncol 2010;28:4441-9.
20. Statius Muller MG, Van Leeuwen PA, De Lange-De Klerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 2001;91:2401-8. (Pubitemid 32552828)
21. Ghaferi AA, Wong SL, Johnson TM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol 2009;16:2978-84.
22. Straume O, Akslen LA. Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 1996;78:1211-9. (Pubitemid 26303886)
23. Leong SP, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg 2005;29:683-91. (Pubitemid 41187526)
24. Borgstein PJ, Meijer S, Van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999;6:315-21. (Pubitemid 29221020)
25. McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001;8:41S-3S.
26. Scoggins CR, Ross MI, Reintgen DS, et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006;24:2849-57. (Pubitemid 46630585)
27. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004;86:212-23. (Pubitemid 38880288)
28. Petersson F, Diwan AH, Ivan D, et al. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival. J Cutan Pathol 2009;36:1157-63.
29. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004;11:247-58. (Pubitemid 40486764)
30. Tefany FJ, Barnetson RS, Halliday GM, et al. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol 1991;97:197-202.
31. Chagpar RB, Ross MI, Reintgen DS, et al. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. J Surg Res 2007;143:164-8. (Pubitemid 47570045)